UPDATE : Friday, August 7, 2020
Regulator OKs Rayence's AI-based X-ray
  • By Lee Han-soo
  • Published 2020.05.06 17:23
  • Updated 2020.05.06 17:23
  • comments 0

Rayence said that the Ministry of Food and Drug Safety has approved Xmaru Pro, an X-ray device that uses artificial intelligence in diagnosing pneumonia.

Xmaru Pro reading image of a lung.

The device, which optimized Vuno's VUNO Med-Chest X-Ray into Rayence's detector device, can detect consolidation, interstitial opacity, pleural effusion, nodule, and pneumothorax, in a chest X-ray image.

"The device can also automatically detect pneumonia, pulmonary tuberculosis, and lung disease in chest X-ray images without an internet connection," the company said. "Until now, medical workers had to go through the process of downloading the captured video image to use AI reading support, connecting to the cloud server over the internet, and send the images."

The whole process took more than 10 minutes, the company added.

The company believes that thanks to the advantage of automatic detection of pneumonia and other findings without an internet connection, medical professionals can significantly increase the speed and accuracy of Covid-19 patient diagnosis and severity screening.

Notably, the device is highly useful in outdoor and mobile screening clinics where communication and network environments are poor, it said.

"In addition to the AI reading support function, the device also includes software that can acquire high-quality images while reducing the radiation dose by 30 percent," Rayence CEO Kim Tae-woo said. "The company will continue to create a new market through technological innovation."


<© Korea Biomedical Review, All rights reserved.>

Other articles by Lee Han-soo
iconMost viewed
Comments 0
Please leave the first comment.
Back to Top